1. Home
  2. AVLN vs MYE Comparison

AVLN vs MYE Comparison

Compare AVLN & MYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$29.89

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Myers Industries Inc.

MYE

Myers Industries Inc.

N/A

Current Price

$27.96

Market Cap

1.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
AVLN
MYE
Founded
2011
1933
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2026
1995

Fundamental Metrics

Financial Performance
Metric
AVLN
MYE
Price
$29.89
$27.96
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $61.80
N/A
AVG Volume (30 Days)
★ 432.2K
313.5K
Earning Date
11-12-2026
10-29-2026
Dividend Yield
N/A
★ 1.91%
EPS Growth
N/A
★ 389.47
EPS
N/A
★ 0.46
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.49
P/E Ratio
★ N/A
$61.76
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$16.66
52 Week High
$40.17
$37.45

Technical Indicators

Market Signals
Indicator
AVLN
MYE
Relative Strength Index (RSI) 58.89 38.72
Support Level $25.86 $26.72
Resistance Level $33.32 $32.10
Average True Range (ATR) 1.93 1.38
MACD 0.67 -0.15
Stochastic Oscillator 74.04 19.73

Price Performance

Historical Comparison
AVLN
MYE

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

About MYE Myers Industries Inc.

Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment manufactures a selection of durable plastic reusable products that are used repeatedly during the course of their service life. The Distribution segment is engaged in the distribution of equipment, tools, and supplies used for tire servicing and automotive under-vehicle repair, etc. It generates the majority of its revenue from the Material Handling segment.

Share on Social Networks: